1. Home
  2. NBHC vs VRDN Comparison

NBHC vs VRDN Comparison

Compare NBHC & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo National Bank Holdings Corporation

NBHC

National Bank Holdings Corporation

HOLD

Current Price

$42.53

Market Cap

2.0B

Sector

Finance

ML Signal

HOLD

Logo Viridian Therapeutics Inc.

VRDN

Viridian Therapeutics Inc.

HOLD

Current Price

$19.70

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBHC
VRDN
Founded
2009
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.2B
IPO Year
2011
2014

Fundamental Metrics

Financial Performance
Metric
NBHC
VRDN
Price
$42.53
$19.70
Analyst Decision
Buy
Strong Buy
Analyst Count
3
14
Target Price
$47.67
$35.46
AVG Volume (30 Days)
398.7K
2.2M
Earning Date
04-21-2026
05-07-2026
Dividend Yield
3.03%
N/A
EPS Growth
N/A
N/A
EPS
0.46
N/A
Revenue
$47,100,000.00
$5,706,000.00
Revenue This Year
$39.96
$13.73
Revenue Next Year
$7.14
$279.00
P/E Ratio
$94.20
N/A
Revenue Growth
2.86
N/A
52 Week Low
$35.06
$13.18
52 Week High
$47.28
$34.29

Technical Indicators

Market Signals
Indicator
NBHC
VRDN
Relative Strength Index (RSI) 42.02 61.76
Support Level $40.68 $15.58
Resistance Level $43.14 $20.00
Average True Range (ATR) 1.00 0.78
MACD -0.35 -0.02
Stochastic Oscillator 15.34 84.22

Price Performance

Historical Comparison
NBHC
VRDN

About NBHC National Bank Holdings Corporation

National Bank Holdings Corp offers a full range of banking products and financial services to commercial, business, and consumer clients predominantly in Colorado, with a focus on personalized service through relationship managers and banking center associates. The company provides commercial and industrial loans, non-owner occupied commercial real estate loans, Small Business Administration loans as a Preferred Lender Provider, U.S. Department of Agriculture and Farm Service Agency loans, commercial deposit and treasury management products, business online and mobile banking, consumer and residential real estate loans, deposit services, and trust and wealth management services. Its services emphasize full-relationship banking, integrating lending, deposits, and cash management solutions.

About VRDN Viridian Therapeutics Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. The company is developing two anti-IGF-1R product candidates, veligrotug for intravenous (IV) administration and elegrobart (formerly VRDN-003) for subcutaneous (SC) administration, to treat patients with TED. Our most advance program, veligrotug, is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of TED.

Share on Social Networks: